A Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is the most lethal and aggressive subtype of breast cancer that lacks an estrogen receptor, the progesterone receptor and the human epidermal growth factor receptor 2 (HER2), making it unsuitable for hormonal- or HER2-based therapy. TNBC is known...

Descripción completa

Detalles Bibliográficos
Autores principales: Tukaramrao, Diwakar Bastihalli, Malla, Saloni, Saraiya, Siddharth, Hanely, Ross Allen, Ray, Aniruddha, Kumari, Shikha, Raman, Dayanidhi, Tiwari, Amit K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074041/
https://www.ncbi.nlm.nih.gov/pubmed/33919653
http://dx.doi.org/10.3390/cancers13081954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074041/
https://www.ncbi.nlm.nih.gov/pubmed/33919653
http://dx.doi.org/10.3390/cancers13081954

Ejemplares similares